DISEASE INDICATIONS: Acute Hepatic Porphyria (AHP)
MANUFACTURER: Alnylam Pharmaceuticals
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Pharmaceuticals and Medical Devices Agency (PMDA)
Givlaari (givosiran) is a medication used to treat acute hepatic porphyria in adult patients and children over the age of 12.